本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Oncolytics Biotech Inc

0.5708
-0.0211-3.56%
成交量:26.21萬
成交額:14.82萬
市值:4,943.18萬
市盈率:-1.98
高:0.6000
開:0.6000
低:0.5548
收:0.5919
資料載入中...
2025/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/24

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]